119. Berlin I, Heilbronner C,Georgieu S, Meier C, Spreux-Varoquaux O. Newborns’ cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers. Drug and Alcohol Dependence, 2010; 107:250-252.

2009

118. Berlin I, Heilbronner C, Georgieu S, Meier C, Launay JM, Spreux-Varoquaux O. Reduced Monoamine Oxidase A Activity in Pregnant Smokers and in Their Newborns.Biol Psychiatry. 2009; 66:728-33.

117. Eiber R, Berlin I. Troubles des conduites alimentaires et tabagisme chez les femmes. Alcoologie et Addictologie 2009 ; 31 : 115-119.

116. Jimenez-Ruis C, Berlin I, Hering T. Varenicline. A novel pharmacotherapy for smoking cessation. Drugs 2009 ; 69 : 1319-1339.

115. Churlaud G, Jacob N, Berlin I: Le tabagisme modifie la perception de saveurs et odeurs. Alcoologie & Addictologie 2009 ; 31: 145-8.

114. Lahmek P, Berlin I, Michel L, Berghout C, Meunier N, Aubin HJ: Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme. Int J Medical Sciences 2009;6:160-7.

113. Berlin I: Therapeutic strategies to optimize the efficacy of nicotine replacement therapies. J of Chronic Obstructive Pulmonary Disease 2009; 6:272–276.

112. Berlin I, Covey LS, Glassman AH: Smoking and depression: a co-morbidity. J of Dual Diagnosis 2009 ; 5:149–158.

111. Leroy C, Bragulat V, Berlin I, Grégoire MC, Bottlaender M, Roumenov D, Dollé F, Bourgeois S, Penttilä J, Artiges E, Martinot JL, Trichard C. Cerebral monoamine oxidase a inhibition in tobacco smokers confirmed with PET and [11C]befloxatone. J Clin Psychopharmacol. 2009; 29:86-8.

110. Berlin I, Perriot J, Letourmy F: Tobacco treatment specialists in France (letter) J. of Smoking Cessation. 2009; 4: 102–103.

109. Aubin HJ, Berlin I, Smadja E, West R: Factors associated with higher body mass index, weight concern, and weight gain in a multinational cohort study of smokers intending to quit. International Journal of Environmental Research and Public Health, 2009; 6:943-957.

108. Lambert C, Berlin I, Tat-Leang Lee TL, Tan ASL MSc (4), Hee SW, Picard D, Han JS: Effect of a Standardized Transcutaneous Acupoint Electric Stimulation Protocol on Relieving Tobacco Urges in Dependent Smokers. Evidence Based Complementary and Alternative
Medicine. 2009 January doi:10.1093/ecam/nen074 [Epub ahead of print]

107. Berlin I : Endocrine and metabolic effects of smoking cessation. Current Medical Research and Opinion 2009; 2: 527–534

2008

106. Berlin I. Smoking-induced metabolic disorders: A review. Diabetes Metab 2008; 34:307-14.

105. Berlin I. Perceived barriers to promoting smoking cessation: A review. J. of Smoking Cessation. 2008; 3: 92-100.

104. Berlin I, Sasco AI: Regulation of smokeless tobacco products. The Lancet 2008; 371: 1504. (Letter)

103. Berlin I, Singleton EG: Does nicotine dependence or urge to smoke predict negative health symptoms in smokers? Preventive Medicine 2008; 47 : 447–451

102. Karila L, Berlin I, Benyamina A, Reynaud M.Psychotic symptoms following buprenorphine withdrawal. Am J Psychiatry. 2008 ;165:400-1(Letter)

2007

101. Lee DC, Myers CS, Taylor RC, Moolchan ET, Berlin I, Heishman SJ. Consistency of subjective responses to imagery-induced tobacco craving over multiple sessions. Addictive Behaviors. 2007 32:2130-9.

100. Berlin I, Gasior MJ, Moolchan ET: Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco dependent smokers. Nicotine and Tobacco Research 2007; 9: 493-498.

2006

99. Berlin I, Covey LS .Precessation depressive mood predicts failure to quit smoking. The role of coping and personality traits. Addiction. 2006;101:1814-21.

2005

98. Berlin I, Covey LS, Jiang H, Hamer D.Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation. Nicotine and Tobacco Research 2005; 7: 725-728.

97. Berlin I, Sachon C, André Grimaldi A: Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus. Diabetes and Metabolism 2005; 31:246-251.

96. Berlin I, Vorspan F, Singleton EG, Warot D, Notides Ch, Heishman SJ: Reliability and validity of the French version of the Tobacco Craving Questionnaire. European Addiction Research 2005; 11:62-68.

95. Berlin I, Vorspan F, Warot D, Manéglier B, Spreux-Varoquaux O : Effect of glucose on tobacco craving. Is it mediated by tryptophan and serotonin? Psychopharmacology. 2005; 178:27-34.

94. Medioni J, Berlin I, Mallet A : Increased risk of relapse rate after stopping nicotine replacement therapies : a mathematical modelling approach. Addiction. 2005; 100: 247-254.

93. Gomez C, Berlin I, Marquis P, Michel Delcroix M : Expired air carbon monoxide concentration in mothers and their spouses above 5 ppm is associated with decreased fetal growth. Preventive Medicine 2005 ; 40 :10-15.
92. Lavergne F, Berlin I, Gamma A, Stassen H, Angst J : Onset of improvement and response to mirtazapine in depression: a multicentre naturalistic study of 4771 patients. Neuropsychiatric Disease and Treatment 2005; 1: 59-68.

2004

91. Aubin HJ, Lebargy F, Berlin I, Bidau-Mazel C, Chemali-Hudry J, Lagrue G: Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomised placebo-controlled trial. Addiction, 2004; 99:1206-18.

90. Corruble E, Berlin I, Lemoine A, Hardy P. Should major depression with 'high normal' thyroid-stimulating hormone be treated preferentially with tricyclics? Neuropsychobiology. 2004; 50:144-6.

89. Robinson ML, Berlin I, Moolchan TE : Tobacco smoking trajectory and associated ethnoracial differences among adolescent smokers seeking cessation treatment. J Adolescent Health. 2004; 35:217-24.

2003

88. Montastruc J-L, Arnaud P, Barbier C, Berlin I, Gatignol C, Haramburu F, Lagier G, Lapyre-Mestre M, Mallaret M, Micaleff J: Critères pharmacologiques d’un médicament pour la substitution de la pharmacodépendance aux opiacés. Thérapie 2003:58:123-125.

87. Berlin I, Gorelick D : The French Law on "Protection of Persons Undergoing Biomedical Research": Implications for the U.S. J of Law, Medicine and Ethics. 2003; 31:434-441.

86. Marra D, Warot D, Berlin I, Hispard E, Dally S : Psychological stress and cortisol secretion in anhedonic alcoholic men. Eur Psychiatry. 2003 ; 18 : 415-417.

85. Berlin I: The Salpetriere hospital: From confining the poor to freeing the insane.Am J Psychiatry. 2003; 160:1579.

84. Skinner M, Aubin HJ, Berlin I,: Impulsivity in smoking, non-smoking, and ex-smoking alcoholics. Addictive Behaviors. 2004; 29: 973-978.

83. Berlin I, Singleton EG, Pedarriosse AM, Lancrenon S, Rames A, Aubin HJ, Niaura R. The Modified Reasons for Smoking Scale. Factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction 2003; 98: 1575-1583.

82. Aymard G, Berlin I, de Brettes B, Diquet B : Pharmacokinetic-pharmacodynamic study of apomorphine’s effect on growth hormone secretion in healthy subjects. Fund Clin Pharmacol. 2003 ; 17 : 473-481.

81. Moolchan TE, Berlin I, Robinson ML , Cadet JL : Characteristics of African American teen smokers who request cessation treatment: Implications for addressing health disparities. Arch Pediatr Adolesc Med. 2003 ; 157 : 533-528.
80. Berlin I, Lavergne F : Relationship between body-mass index and depressive symptoms in patients with major depression. European Psychiatry. 2003 ; 18 : 85 - 88.